Highview Capital Management LLC Merck & Co., Inc. Transaction History

Highview Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$108.61 - $118.38 $10,861 - $11,838	-100 Reduced 1.03%	9,569 $1.1 Million
Q1 2023 Apr 26, 2023	BUY	$102.94 - $114.86 $19,764 - $22,053	192 Added 2.03%	9,669 $1.03 Million
Q4 2022 Jan 30, 2023	BUY	$87.44 - $112.11 $27,281 - $34,978	312 Added 3.4%	9,477 $1.05 Million
Q3 2022 Nov 01, 2022	BUY	$84.53 - $94.96 $170,327 - $191,344	2,015 Added 28.18%	9,165 $789,000
Q2 2022 Jul 25, 2022	SELL	$83.49 - $94.64 $35,316 - $40,032	-423 Reduced 5.59%	7,150 $652,000
Q1 2022 Apr 28, 2022	BUY	$73.51 - $82.4 $261,989 - $293,673	3,564 Added 88.9%	7,573 $621,000
Q4 2021 Jan 28, 2022	BUY	$72.28 - $90.54 $289,770 - $362,974	4,009 New	4,009 $307,000

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Highview Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highview Capital Management LLC with notifications on news.